Fig. 1.

Flow chart of the study: referral to clinics, selection of patients according to instrumental evaluation proposed by Consortium Consensus criteria, and drug effect assessments. The comparative analysis was performed only in patients whose diagnosis was not challenged during the follow-up. The asterisk indicates that the two patients who developed PDD during follow-up were considered in the 65 patients of the PD group